Zobrazeno 1 - 10
of 166
pro vyhledávání: '"L, Paimela"'
Autor:
Hannu Kautiainen, Juha Risteli, S Aman, M Hakala, L. Paimela, T. Helve, Marjatta Leirisalo-Repo
Publikováno v:
Rheumatology. 39:1009-1013
Objective. To test the predictive value of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP; a marker of type I collagen degradation), rheumatoid factor (RF ) and C-reactive protein (CRP) for disease progression in patients with
Publikováno v:
Acta Radiologica. 37:572-577
Purpose: To establish the diagnostic usefulness of ultrasonography (US) and MR imaging in patients with rheumatoid arthritis (RA) suffering from prolonged pain in the ankle region, where plain radiography did not demonstrate any changes. Material and
Publikováno v:
Scandinavian Journal of Rheumatology. 25:92-96
We studied chemiluminescence (CL) responses and chemotaxis of monocytes of patients with early rheumatoid arthritis (RA) before starting anti-rheumatic drug treatment and correlated the data to 2-year prognosis of the patients. Luminol-enhanced CL re
Autor:
M, Hakala, H, Kröger, H, Valleala, T, Hienonen-Kempas, M, Lehtonen-Veromaa, J, Heikkinen, T, Tuomiranta, P, Hannonen, L, Paimela, Tea, Uusitalo
Publikováno v:
Scandinavian journal of rheumatology. 41(4)
Objectives: To study the efficacy and safety of once-monthly oral ibandronate in the prevention of glucocorticoid (GC)induced osteoporosis (GIOP) in postmenopausal women with inflammatory rheumatic diseases. Method: A randomized, double-blind, placeb
Publikováno v:
Clinical and experimental rheumatology. 26(3)
To study amyloidosis as a cause of death along with associated factors and frequency of pre-mortem diagnosis in patients with rheumatoid arthritis (RA) autopsied between 1952 and 1991.We studied causes of death in 369 consecutively autopsied RA and 3
Autor:
M. Hakala, J. Risteli, S. Åman, H. Kautiainen, M. Korpela, P. Hannonen, M. Leirisalo‐Repo, L. Laasonen, L. Paimela, T. Möttönen, null for the FIN‐RACo Trial Group
Publikováno v:
Scandinavian journal of rheumatology. 37(2)
To assess whether serum C-terminal cross-linking telopeptide of type I collagen (ICTP), a marker of type I collagen degradation, has any additional value in the assessment of treatment effect in patients with early rheumatoid arthritis (RA).A total o
Publikováno v:
Scandinavian journal of gastroenterology. 37(4)
Medical therapy of peptic ulcer disease (PUD) has improved dramatically during the past 20 years with the introduction of modern antisecretory drugs as well as eradication therapy of Helicobacter pylori. During the 1990s, there has been a 3-fold incr
Publikováno v:
The Journal of rheumatology. 27(3)
To investigate the effect of age on clinical and radiological outcome and on efficacy and tolerance of antirheumatic therapy in early rheumatoid arthritis (RA).In a prospective 3 year study 113 patients (83 women, 30 men) were divided into 2 groups a
Autor:
T, Möttönen, P, Hannonen, M, Leirisalo-Repo, M, Nissilä, H, Kautiainen, M, Korpela, L, Laasonen, H, Julkunen, R, Luukkainen, K, Vuori, L, Paimela, H, Blåfield, M, Hakala, K, Ilva, U, Yli-Kerttula, K, Puolakka, P, Järvinen, M, Hakola, H, Piirainen, J, Ahonen, I, Pälvimäki, S, Forsberg, K, Koota, C, Friman
Publikováno v:
Lancet (London, England). 353(9164)
The treatment of rheumatoid arthritis should aim at clinical remission. This multicentre, randomised trial with 2-year follow-up sought evidence on the efficacy and tolerability of combination therapy (sulphasalazine, methotrexate, hydroxychloroquine
Autor:
J TEIR, J GRAY, A PENDLEBURY, D M GRENNAN, T. MOTTONEN, L. PAIMELA, M. LEIRISALO-REPO, H. KAUTIAINEN, J ILONEN, P. HANNONEN
To investigate the prognostic significance of clinical and genetic markers on the outcome of patients with recent-onset rheumatoid arthritis (RA) treated actively with slow acting antirheumatic drugs (SAARDs).A total of 142 consecutive patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::573394d49f6aa9d23780c9466a227d46
https://europepmc.org/articles/PMC1752879/
https://europepmc.org/articles/PMC1752879/